MDXHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
12 dec 2006 - 23:31
Statutaire naam
MDXHealth
Titel
OncoMethylome Sciences Licenses Second Prostate Cancer Test to Veridex
Bericht
Liege (BELGIUM) – December 13, 2006, 8:00am CET – OncoMethylome Sciences (Euronext: ONCO) announced today that it successfully completed the initial research activities of its urine-based prostate cancer test, and that the test has been licensed to Veridex LLC, a Johnson & Johnson company.
Datum laatste update: 22 december 2025